Showing 11 - 20 of 107 results
A new defense against prostate cancer, the most common cancer in men in the United States, may come from a seaweed found off the coast of Florida. University of Florida pharmacy researchers have screened various seaweeds with cancer-preventive potential and identified one that shows particular promise. They isolated specific compounds in this common green alga,...
hendrik luesch Discovering a new wave of medicine The ocean is calling and beneath its surface dwells an unseen power to heal. Dr. Hendrik Luesch explores the world’s oceans in search of natural compounds that treat cancer and other deadly diseases. In these uncharted waters, lies new chemistry, new biology…
A two-year, $400,000 grant from the National Institute on Alcohol Abuse and Alcoholism, or NIAAA, will allow University of Florida College of Pharmacy researchers to study alcohols' effects on relationships.
Led by principal investigator, Rob Huigens, Ph.D., an assistant professor of medicinal chemistry, the grant aims to establish a drug discovery pipeline to generate and identify new small molecules that possess anticancer activities.
Graduate student Campbell Eckhardt has been selected for a 2025 National Science Foundation Graduate Research Fellowship Program award.
College of Pharmacy College of Medicine Department of Chemistry Department of Biology Department of Microbiology and Cell Science Department of Chemical Engineering
NIH/NIGMS Chemistry-biology interface predoctoral training program at the university of florida The predoctoral training program led by researchers at the University of Florida will help train the next generation of biomedical scientists and interface their interests in chemistry and biology. Through this training program, UF is preparing young scientists with the…
UF Health honored 33 endowed professors and chairs across the six academic colleges at a special Celebrating Distinction ceremony on Oct. 13.
Mission The mission of the Center for Natural Products, Drug Discovery and Development, or CNPD3, is to foster early-stage drug discovery by providing the infrastructure, chemical libraries and expertise to screen for disease-relevant targets and for drug-like disease-modifying molecules that modulate target activity. The CNPD3 provides the academic home for the identification of drug leads...
